Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye

Intracameral injection of bevacizumab (Avastin) helped in the successful regression of an anterior chamber neovascular membrane in a painful blind eye. The effect was persistent even after six months of follow-up. This is the first report on intracameral administration of bevacizumab with six months...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghuram, A, Saravanan, VR, Narendran, V
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2007
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635977/
https://www.ncbi.nlm.nih.gov/pubmed/17951906
_version_ 1782164243637862400
author Raghuram, A
Saravanan, VR
Narendran, V
author_facet Raghuram, A
Saravanan, VR
Narendran, V
author_sort Raghuram, A
collection PubMed
description Intracameral injection of bevacizumab (Avastin) helped in the successful regression of an anterior chamber neovascular membrane in a painful blind eye. The effect was persistent even after six months of follow-up. This is the first report on intracameral administration of bevacizumab with six months of follow-up.
format Text
id pubmed-2635977
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-26359772009-02-10 Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye Raghuram, A Saravanan, VR Narendran, V Indian J Ophthalmol Brief Report Intracameral injection of bevacizumab (Avastin) helped in the successful regression of an anterior chamber neovascular membrane in a painful blind eye. The effect was persistent even after six months of follow-up. This is the first report on intracameral administration of bevacizumab with six months of follow-up. Medknow Publications 2007 /pmc/articles/PMC2635977/ /pubmed/17951906 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Raghuram, A
Saravanan, VR
Narendran, V
Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
title Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
title_full Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
title_fullStr Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
title_full_unstemmed Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
title_short Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
title_sort intracameral injection of bevacizumab (avastin) to treat anterior chamber neovascular membrane in a painful blind eye
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635977/
https://www.ncbi.nlm.nih.gov/pubmed/17951906
work_keys_str_mv AT raghurama intracameralinjectionofbevacizumabavastintotreatanteriorchamberneovascularmembraneinapainfulblindeye
AT saravananvr intracameralinjectionofbevacizumabavastintotreatanteriorchamberneovascularmembraneinapainfulblindeye
AT narendranv intracameralinjectionofbevacizumabavastintotreatanteriorchamberneovascularmembraneinapainfulblindeye

Ejemplares similares